Results 171 to 180 of about 34,974 (214)
Some of the next articles are maybe not open access.
[Haemophilus influenzae vaccines].
Bulletin de l'Academie nationale de medecine, 1994The haemophilus vaccines are made of the type b capsular polysaccharide of haemophilus influenzae, polyribosylribitol phosphate (PRP), which is responsive of pathogenic power. However the responsiveness of children to PRP vaccine was found to be very poor in infants.
openaire +1 more source
Haemophilus influenzae type b vaccination
The Lancet, 1997A, Melhus, A, Hemansson
openaire +3 more sources
Haemophilus b Polysaccharide Vaccine-Reply
JAMA: The Journal of the American Medical Association, 1989In Reply. — We congratulate Coles et al on the innovative use of discharge diagnosis data, and we agree with the conclusion that the polysaccharide Haemophilus vaccine provided protective efficacy in children aged 24 to 59 months. A randomized trial of the vaccine in Finland 1 as well as three postlicensure case-control studies 2-4 all demonstrated a ...
openaire +1 more source
Third Vaccine for Haemophilus influenzae?
JAMA: The Journal of the American Medical Association, 1991THE WAY has been opened to license a third vaccine againstHaemophilus influenzaefor use in 2-month-old infants. Pasteur Merieux, Swiftwater, Pa, the manufacturer of the third vaccine, was in the midst of two double-blind, placebo-controlled studies a year ago when the Food and Drug Administration (FDA) licensed a vaccine againstH influenzaeto Lederle ...
openaire +1 more source
Haemophilus influenzae type b polysaccharide vaccines
The Journal of Pediatrics, 1985D M, Granoff, K L, Cates
openaire +2 more sources